Base
Notice2026-196462026-09-25

Request for Information; Domestic and Near Shore Manufacturing of Essential Medicines on the ASPR 86 List

Management and Budget Office

Abstract

The Office of Management and Budget (OMB) is conducting market research to identify new and unused (idle) domestic, U.S.-based, and near shore production capabilities for Finished Dose Forms (FDF), Active Pharmaceutical Ingredients (API), and Key Starting Materials (KSM) associated with the Administration for Strategic Preparedness and Response (ASPR) 86 list of essential medicines. Responses will be shared with federal agencies that have requirements for essential medicines or responsibilities for strengthening the domestic industrial base for essential generic pharmaceuticals.

Action & Dates

Action
Request for information.
Dates
Responses to this request for information will be accepted for consideration until October 26, 2026.

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Office of Management and Budget AGENCY: Office of Management and Budget. ACTION: Request for information. SUMMARY: The Office of Management and Budget (OMB) is conducting market research to identify new and unused (idle) domestic, U.S.-based, and near shore production capabilities for Finished Dose Forms (FDF), Active Pharmaceutical Ingredients (API), and Key Starting Materials (KSM) associated with the Administration for Strategic Preparedness and Response (ASPR) 86 list of essential medicines. Responses will be shared with federal agencies that have requirements for essential medicines or responsibilities for strengthening the domestic industrial base for essential generic pharmaceuticals. DATES: Responses to this request for information will be accepted for consideration until October 26, 2026. ( printed page 60984) ADDRESSES: Responses must be submitted electronically through regulations.gov. Mailed paper submissions will not be accepted, and electronic submissions received after the deadline may not be considered. Instructions: Federal eRulemaking Portal: Go to www.regulations.gov search “Domestic and Near Shore Manufacturing of Essential Medicines RFI” to submit your comments electronically. Information on how to use Regulations.gov, including instructions for accessing agency documents, submitting comments, and viewing the docket, is available on the site under “FAQ” ( https://www.regulations.gov/​faq ). Should you choose to include propri…

Read full document on FederalRegister.gov →

Full Document

Citation: 91 FR 60983